p112: safe driving and alzheimer’s disease

Authors

tahereh ghadiri shefa neuroscience research center, khatam alanbia hospital, tehran, iran.

mostafa modarres mousavi shefa neuroscience research center, khatam alanbia hospital, tehran, iran.

sajad sahab negah shefa neuroscience research center, khatam alanbia hospital, tehran, iran.

arezou eshaghabadi shefa neuroscience research center, khatam alanbia hospital, tehran, iran.

abstract

people with alzheimer disease (ad) have decreases in brain cell function that may increase their risks as drivers. the changes in brain cells affect memory (at first, short-term memory and then much later, long-term memory) and other thinking functions. in addition, people with early ad, though often very functional in many areas of life, may not be as competent behind the wheel of a car as those without the memory-damaging disease. furthermore, many people with ad and their families are not aware how dementia affects a person’s driving abilities, often until there has been an incident involving an accident, getting lost while driving or other driving crisis. the need for overall education around this issue is critical. in addition, the declining cognitive abilities of a person with ad will ultimately lead to the need for the individual to stop driving. it is difficult to determine when restrictions are needed because little solid evidence exists linking various stages of dementia with driving behavior. however, at some point in the progression of the disease, driving performance errors will present a safety risk to both the individual and the public. in conclusion, the person with ad should participate in the planning and decision making regarding the cessation of driving. furthermore, driving demands quick reaction time and fast decision making because of this, a person with ad will eventually become unable to drive. however, driving privileges must be withheld when the individual poses a serious risk to self or others.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

P112: Safe Driving and Alzheimer’s Disease

لطفاً به چکیده انگلیسی مراجعه شود.

full text

Magnesium and Alzheimers Disease: The Cholinergic Hypothesis

The cholinergic deficit in Alzheimer’s disease (AD) remains the cornerstone for the understanding of chemical signal transfer. Hypofunctions of cholinergic systems are significantly involved in the signs and symptoms of senile dementia of the Alzheimer type. Cognitive deficits in AD have been widely associated with dysfunction of the cholinergic system. As a diagnostic marker of AD the activity...

full text

Syncope while driving: how safe is safe?

As healthcare providers, our primary role is the diagnosis and management of the medical conditions of our patients. These medical conditions have an important impact on their personal lives as well as social situations. One of the most critical such interactions between a patient’s medical condition and society is syncope as it relates to driving. In our society, there is a constant conflict b...

full text

P92: Importance of Adequate Sleep Time in Safe Driving

لطفاً به چکیده انگلیسی مراجعه شود.

full text

Glucose Role in Treatment of Alzheimers’ Disease

1. Dong H, Csernansky JG (2009) Effects of Stress and Stress Hormones on Amyloidβ Protein and Plaque Deposition. J Alzheimers Dis 18: 459-469. 2. Csernansky JG, Dong H, Fagan AM, Wang L, Xiong C, et al. (2006) Plasma cortisol and progression of dementia in subjects with Alzheimer‐ type dementia. Am J Psychiatry 163: 2164-2169. 3. Swaab DF, Raadsheer FC, Endert E, Hofman MA, Kamphorst W, et al. ...

full text

My Resources

Save resource for easier access later


Journal title:
مجله علوم اعصاب شفای خاتم

جلد ۲، شماره ۴، صفحات ۱۶۲-۱۶۲

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023